. Author manuscript; available in PMC: 2022 Dec 19.

Published in final edited form as: Mamm Genome. 2022 Jul 11;33(4):575–589. doi: 10.1007/s00335-022-09957-w

Table 2.

Relationships between iAs exposure and metabolic indicators

Indicator	iAs exposure		iAs exposure x %fat		iAs exposure x Weight		Covariates^a
	Beta [95% CI]	p	Beta [95% CI]	p	Beta [95% CI]	p

FPI	−0.16 [−0.32,0.01]	0.072	0.29 [0.11,0.47]	0.003			B, W, iAS, P, iAs*P
PI15	−0.05 [−0.21,0.11]		0.18 [−0.03,0.38]	0.099			B, W, iAs, P, iAs*P
FBG	−3.50 [−10.21,3.20]						B, W, iAs
BG15	−18.22 [−43.17,6.73]						B, W, iAs, P, W*P
HOMA-B	−91.72 [−389.80,206.36]				362.78 [139.32,586.24]	0.002	W, iAs, W*iAs
HOMA-IR	−5.94 [−15.96,4.08]				6.73 [−0.78,14.24]	0.084	W, iAs, W*iAs
Ins. Index	0.16 [−0.16,0.34]						iAs

A*B indicates an interaction between A and B

W body weight, iAs cumulative inorganic arsenic exposure, P percent body fat

B = Baseline (week -1) indicator value